We are live on ! Find out more
GNPX icon

Genprex
GNPX

25 hedge funds and large institutions have $9.78M invested in Genprex in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

40% more call options, than puts

Call options by funds: $447K | Put options by funds: $319K

0% more ownership

Funds ownership: 0% → 0% (+0%)

11% less funds holding

Funds holding: 28 → 25 (-3)

38% less capital invested

Capital invested by funds: $15.8M → $9.78M (-$6.02M)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
2
Closed
7
Calls
$447K
Puts
$319K
Net Calls
+$128K
Net Calls Change
+$315K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.5M
2
AFM
Anson Funds Management
Texas
+$834K
3
Renaissance Technologies
Renaissance Technologies
New York
+$584K
4
Millennium Management
Millennium Management
New York
+$250K
5
Group One Trading
Group One Trading
Illinois
+$167K

Top Sellers

Rank Fund Capital Flow
1
E
Ergoteles
New York
-$200K
2
HF
HRT Financial
New York
-$183K
3
GCP
GSA Capital Partners
United Kingdom
-$167K
4
Citadel Advisors
Citadel Advisors
Florida
-$83.4K
5
Simplex Trading
Simplex Trading
Illinois
-$83.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.41M – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$1.18M +$584K +7 +50%
Morgan Stanley
3
Morgan Stanley
New York
$1.13M +$1.5M +18 +900%
BlackRock
4
BlackRock
New York
$758K +$83.4K +1 +8%
Millennium Management
5
Millennium Management
New York
$582K +$250K +3 +43%
AFM
6
Anson Funds Management
Texas
$575K +$834K +10 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$491K – – –
GCP
8
GSA Capital Partners
United Kingdom
$398K -$167K -2 -22%
UBS Group
9
UBS Group
Switzerland
$360K – – –
Group One Trading
10
Group One Trading
Illinois
$242K +$167K +2 +100%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$164K +$83.4K +1 +50%
VF
12
Virtu Financial
New York
$164K +$167K +2 +200%
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$152K -$83.4K -1 -25%
State Street
14
State Street
Massachusetts
$144K – – –
CC
15
Cypress Capital
Tennessee
$131K – – –
Northern Trust
16
Northern Trust
Illinois
$103K – – –
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$101K +$83.4K +1 +100%
Two Sigma Investments
18
Two Sigma Investments
New York
$95K +$167K +2 New
SAM
19
Silvercrest Asset Management
New York
$73K – – –
IWM
20
IHT Wealth Management
Illinois
$69K – – –
SCA
21
STALEY CAPITAL ADVISERS
Pennsylvania
$66K – – –
SWM
22
Spire Wealth Management
Virginia
$52K – – –
SG
23
StoneX Group
New York
$46K – – –
TSS
24
Two Sigma Securities
New York
$42K +$83.4K +1 New
Goldman Sachs
25
Goldman Sachs
New York
$29K +$83.4K +1 New
1
2 3

GNPX Hedge Fund Activity: Q4 2021 in Review

25 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q4 2021, worth a combined $9.78M — down 38% from $15.8M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of GNPX and 4 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 8 added.

The largest buyer was Morgan Stanley, adding an estimated $1.5M. The largest seller was Ergoteles, exiting entirely with an estimated $200K sold.

  • 25 institutional investors held Genprex (GNPX) as of Q4 2021, down from 28 in Q3 2021.
  • Funds reported $9.78M of Genprex stock for Q4 2021, down 38% quarter-over-quarter.
  • 4 funds opened new Genprex positions in Q4 2021 and 7 closed out, a net change of -3 holders.
  • The largest Genprex buyer in Q4 2021 was Morgan Stanley, an estimated $1.5M added.
  • The largest Genprex seller in Q4 2021 was Ergoteles, an estimated $200K sold.

Based on aggregated 13F filings for Q4 2021.